Anti-angiogenic and antitumor effects of anlotinib combined with bevacizumab for colorectal cancer

Background: The progression and metastasis of tumors are typically accompanied by angiogenesis. Crucially, vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) play a significant role in tumor-associated angiogenesis. In this study, the aim was to investigate the antitumor effect of...

Full description

Bibliographic Details

Published in:	Translational Oncology
Main Authors:	Min Yan, Ronghao Yang, Qi Li, Chenjie Wang, Jiali Chen, Zhenying Wu, Han Li, Juan Fan
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Subjects:	Anti-angiogenesis Anlotinib Bevacizumab Multi-target treatment Colorectal cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523324000135